New Research Power Ups Psilocybin's Potential as an Antidepressant

Health and Medicine

GEN - Genetic Engineering and Biotechnology News

2024-05-02

New Research Power Ups Psilocybin’s Potential as an Antidepressant

A team of researchers sought to determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs.

Check it out!

Related News

Live and Awake in LA

Having attended the surprisingly few SoCal events over the past few years, it was such a welcome pleasure to see familiar faces coming together in LA for 3 days of meaningful conversations centered around healing, community, access, learning, and networking at Psychedelic Awakening 2025 hosted by Psychedelic Institute of Los Angeles.

Most Of Mental Health Professionals Want Psychedelic Theraphy

A survey reveals that the majority of mental health professionals are open to psychedelic therapy, if legalized and properly regulated.

Can magic mushrooms mend the mind? Researchers map psilocybin’s mysterious brain effects – but key questions remain

Researchers found that psilocybin disrupts normal brain communication, increasing connectivity between different brain networks. These changes might explain psilocybin’s therapeutic effects, but questions remain about its true impact and how it influences feelings and behavior.

Why Indigenous “Spirit medicine‚” principles must be a priority in psychedelic research

Yuria Celidwen, a UC Berkeley Othering and Belonging Institute senior fellow, sheds light on how Western institutions can ethically approach the use of psychedelics.

Can a Combination of Psychedelics and Meditation Help Treat Depression

According to a recent study, a combination of meditation and hallucinogens can be used as a form of therapy to help individuals suffering from depression.